A flow-rate prescription is not a number plucked from a chart. It is the output of a short clinical loop: measure the saturation deficit, choose a target SpO2 band based on the patient’s underlying physiology, titrate flow upward in small steps until the target is reached, and then check whether that flow holds across rest, exertion, and sleep. The cheapest mistake in Indian home-oxygen practice is treating “2 LPM” or “5 LPM” as a constant. It is not. It is a setpoint that must be earned and re-checked.
This guide walks through how an SpO2 measurement becomes a flow-rate prescription, where the bands sit, when to escalate, and how Indian-specific conditions — coastal humidity, voltage variance, hill-station altitude, the realities of the dealer channel — change the prescription in practice.
SpO2 measurement: pulse oximetry and where it fails
Pulse oximetry is the workhorse for outpatient titration. A finger probe shines red and infrared light through the capillary bed, the absorption ratio is converted to an estimate of oxyhaemoglobin saturation, and the number drops on a screen. For most home-oxygen decisions this is enough. Probe-to-ABG agreement is typically within ±2% in the 90-100% range, deteriorating at lower saturations and in the presence of motion, cold extremities, dark nail polish, or low perfusion.
Where pulse oximetry is the wrong tool: any clinical question that depends on PaO2 (the dissolved oxygen tension), PaCO2 (carbon dioxide), or pH. CO2 retention, the pivotal question for COPD and obesity hypoventilation, is invisible to a fingertip probe. Carboxyhaemoglobinaemia (in heavy smokers, fire-injury patients, biomass-cooking exposure) confuses the absorption ratio and can read falsely normal. Methaemoglobinaemia pins the reading near 85% regardless of true saturation. Any LTOT decision, any NIV initiation, and any acute deterioration assessment needs an arterial blood gas, not just an oximeter (British Thoracic Society).
The Indian outpatient pattern: oximeter at home for daily checks and titration verification, ABG at the pulmonologist’s office or a tertiary lab at initial workup and at six-month review. A ₹1,500-₹3,000 fingertip oximeter is now standard issue with any LTOT prescription and is the single most useful instrument the patient owns.
Target SpO2 bands by physiology
The target band drives everything downstream. Three bands matter:
88-92% for COPD CO2-retainers and patients at risk of hypercapnic ventilatory failure. Aggressive normoxia in this group can suppress hypoxic respiratory drive, raise PaCO2, and trigger acute hypercapnic acidosis. The instinct to push the saturation to “look healthy” is wrong. The correct answer is the lowest flow that holds 88-92% reliably.
92-96% for non-retainers with chronic respiratory disease. Most ILD, post-COVID fibrotic disease, pulmonary hypertension, bronchiectasis, and stable left-heart-failure patients fit here. There is no upside to pushing past 96% in chronic stable disease and no large clinical signal to favour a tighter band.
94-98% for acute illness without retention risk. Hospitalised pneumonia, acute heart failure, pulmonary embolism, post-operative recovery. The band is wider on top because acute physiology is changing fast and a buffer matters. (British Thoracic Society).
When the underlying physiology is unclear — for example, an elderly smoker with overlap COPD-ILD-cardiac picture — default to 88-92% until the workup clarifies. Erring low is safer than erring high in any patient with potential CO2 retention.
The titration walk-through
A standard outpatient titration runs as follows:
- Patient at rest for 5-10 minutes on room air. Record baseline SpO2.
- Start oxygen at 1 LPM via standard nasal cannula. Wait 5 minutes for equilibration. Record SpO2.
- If SpO2 is below the target band, escalate by 0.5-1 LPM. Wait 5 minutes. Re-check.
- Continue until SpO2 sits inside the target band consistently across two consecutive measurements 5-10 minutes apart.
- Record the flow that achieved this. That is the resting prescription.
The resting prescription is the floor, not the ceiling. The next two questions are exertion and sleep.
Exertion titration. Walk the patient on the prescribed flow for 6 minutes (or the longest comfortable distance). Re-check SpO2 immediately on stopping. If the patient drops more than 4% below target during the walk, exertion flow needs to go up — typically by 1-2 LPM above the resting setting. A patient sitting comfortably on 2 LPM may need 3-4 LPM to climb a flight of stairs without crashing.
Nocturnal titration. Most patients desaturate further at night because of REM-related hypoventilation, supine ventilation-perfusion mismatch, and reduced airway tone. An overnight pulse-oximetry recording — there are now ₹4,000-₹8,000 recording oximeters available in the Indian market — captures the lowest, mean, and time-below-90% saturation. If the nocturnal mean falls more than 3% below the resting daytime mean, nocturnal flow may need to be 0.5-1 LPM higher than the daytime setting.
A useful rough rule for first-pass dosing: every 1-2% of saturation deficit below target tends to require roughly 0.5-1 LPM. A patient sitting at 86% on room air with a 90% target will commonly land near 2 LPM. A patient at 80% will commonly need 4-5 LPM. These are guides, not prescriptions — the titration itself is the prescription.
Continuous, nocturnal-only, and exertion-only patterns
Three clinical patterns map to three different equipment strategies.
Continuous LTOT. Resting hypoxaemia at SpO2 ≤ 88% (or PaO2 ≤ 55 mmHg) drives 15+ hours/day prescription. The right device is a stationary 5 LPM concentrator running essentially 24/7, ideally with a portable concentrator for ambulation if the patient leaves the house regularly (GOLD Report).
Nocturnal-only oxygen. Daytime SpO2 stays ≥ 90% but overnight falls below 88% for >30% of total sleep time, or mean nocturnal SpO2 < 90%. Common in stable COPD with mild daytime impairment, post-COVID interstitial disease in recovery, and certain heart-failure phenotypes. A 5 LPM stationary concentrator running 8-10 hours a night with a humidifier solves this. Evidence on mortality benefit from isolated nocturnal oxygen is mixed, but symptomatic benefit and right-heart protection in selected patients is reasonable.
Exertion-only oxygen. Daytime and nocturnal saturation adequate at rest, but exertional desaturation drops below 88% during ADLs. Pulmonary rehab and ILD populations dominate this group. A portable concentrator (3-5 pulse-dose settings) used during walks, errands, and exercise covers it.
The wrong pattern: a patient who needs continuous oxygen but has been sold “use it only when you feel breathless.” Reactive use is undertreatment. Continuous LTOT delivers its mortality benefit specifically because the patient is on it for ≥15 hours a day, not because the saturation gets corrected during dyspnea episodes.
When to escalate flow vs add a second device
If the prescribed flow stops holding the target band, the question is whether the patient needs more flow from the same machine, more flow than a single 5 LPM unit can provide, or a different therapy entirely.
Escalate within the same device if the patient is on a 5 LPM concentrator running at 3-4 LPM and the saturation drift is small and gradual. Step up by 0.5 LPM and verify with a 6-minute walk and an overnight pulse-oximetry recording. Most 5 LPM concentrators deliver their rated flow with full purity to about 4 LPM and then trade purity for flow above that — verify the unit is still putting out ≥90% O2 at the new setpoint.
Move to a 10 LPM concentrator if the resting requirement crosses 5 LPM, if exertion needs 6-8 LPM consistently, or if a second person in the household also needs oxygen and a single 5 LPM cannot supply both via Y-splitter without purity collapse. The Home Medix HM-KX 10 LPM, Oxymed Mini 10, Philips EverFlo Q (5 LPM, but paired) and several Chinese OEM 10 LPM units occupy this segment in India.
Add NIV if the patient is hypercapnic and oxygen alone cannot fix the underlying ventilation problem. A patient on 4 LPM whose CO2 climbs into the 60s mmHg needs BiPAP-ST, not more oxygen. This is the single most common escalation error in the Indian home-oxygen market: pushing flow up on a CO2-retainer until the saturation looks good while the patient becomes obtunded from CO2 narcosis.
Indian context: humidity, altitude, voltage, and dealer reality
Coastal monsoon humidity. Mumbai, Chennai, Kochi, Visakhapatnam and Kolkata patients during May-September often need 0.5-1 LPM more flow than their dry-season prescription. Two mechanisms: zeolite sieve performance degrades with absorbed moisture, dropping concentrator output purity by 1-3 percentage points, and patients tolerate cannula flow worse with mucosal irritation, leading to mouth breathing and effective dose loss. The right response is a humidifier on the concentrator, regular sieve-bed inspection, and a low threshold to titrate up by 0.5 LPM during peak monsoon.
Hill-station altitude. Concentrators sold in India are calibrated at sea-level pressure. At Manali (2050m), Shimla (2200m), Gangtok (1600m), Munnar (1500m), Mussoorie (2000m) and especially Leh (3500m), the partial pressure of oxygen at the inlet is lower, sieve adsorption is less efficient, and the same flow setting delivers a lower effective FiO2 to the patient. Most 5 LPM machines lose 10-15% rated capacity at 2000m and 25-35% at 3500m. A Manali patient on a sea-level 3 LPM prescription often needs 4 LPM at home.
Voltage variance. A 5 LPM concentrator draws 350-500W; a 10 LPM unit 600-900W. Tier-2 city mains in the 160-260V range stress unprotected compressors and shorten life. A 1-2 kVA servo stabiliser is the minimum at install; pure-sine inverter with 4-6 hour battery backup if the patient is on continuous LTOT and the local grid drops out for stretches.
Dealer channel and pulmonologist routing. Self-titration without pulmonologist involvement is the largest failure mode in the Indian home-oxygen market — patients arrive at the dealer with a fingertip oximeter, a guess, and a budget. The right path is: workup with a pulmonologist, formal titration (ideally including a 6-minute walk and overnight oximetry), written prescription specifying flow at rest, exertion and sleep, then equipment purchase against that prescription. Dealers cannot legitimately set flow rates. They can size the machine class (5 LPM stationary vs 10 LPM vs portable) against a written prescription.
The takeaway
A flow rate is a measurement, not a guess. Target band by physiology, titrate upward in 0.5-1 LPM steps, verify across rest, exertion and sleep, then re-check at three to six months. The Indian patient buying a concentrator on the basis of a single resting SpO2 reading and a dealer’s recommendation is buying a machine that may or may not match the actual oxygen need. The cost of getting this wrong is not equipment cost — it is a patient who is undertreated, overtreated, or, in the CO2-retainer case, made worse.
This guide is editorial opinion and general information. It is not medical advice. Consult your physician for therapy decisions, and verify all specifications with the manufacturer before purchase.